Taken together, our results suggest that Notch1 signaling is a key regulator under conditions in which mitochondrial function in ECs of the BBB is disrupted and strengthen the effect of Notch1 signaling as a therapeutic target for maintaining BBB integrity in cerebrovascular disease. Here, NOTCH1 is linked to cerebrovascular disorder.